ProSeek Bio’s Post

AccendoWave - A Pain #Data Company While longer life expectancies for men and women have been a societal success story, this is not the full picture. Despite living longer than men, women spend 25% more of their lives in poor health. Health burdens have a heavy impact on women’s lives, with ripple effects for broader society. To address these issues, the World Economic Forum and the McKinsey Health Institute have released a new insight report as part of the Forum's Women’s Health Initiative. The report addresses the root causes of the women’s health gap (focused on science, data, care delivery and investment) and charts a number of ways forward to close this gap – from incentivizing new financing models to investing in women-centric research and implementing more inclusive health policies. Addressing the women’s health gap could potentially boost the global economy by at least $1 trillion annually by 2040. Investing in women's health – which is more than just sexual or reproductive health – is therefore not only a matter of health equity, but a chance to help women have expanded workforce participation. Most importantly, it would help them live healthier lives. A Top 4 Global Health Equity Solution and Top 15 Global Remote Monitoring Company, AccendoWave, benchmarks objective brain wave pain data (specialty, gender, age) and has nine #pain databases: Emergency Department, Maternal Health, Oncology, MSK, Medical Surgical, ICU, Women, Adults, Seniors to eliminate bias, improve outcomes and reduce health care costs. If desired, AccendoWave can also create customized pain databases for partners that can be accessed on the Datavant platform.

Collaboration not competition – that is what will improve outcomes in our field. That’s why on the evening of this #WomensHealthWednesday I want to highlight another report highlighting the challenges, needs, and impact of Women’s Health from (admittedly competitor) Accenture and Springboard Enterprises – "State of Women’s Health" https://lnkd.in/eWc4H6p4 I particularly thought their section called “Under-Researched” was critical to highlight. What are the implications of women being under-represented in clinical trials? Well actually monumental! By now – many know that prior to 1993 women weren’t even mandated to be included in clinical trials. This report shows however, that even over the last 5 years, female representation in clinical trials tends to be 12-27% lower than disease prevalence for each condition (see image below). The report goes on to show a case study of the implications – it took dozens of years and many clinical studies to lower the recommended dosage of sedative zolpidem, which had been causing cognitive deficit in women. Just like children are not small adults, women are not smaller men. Women metabolize drugs differently. Not only that – women metabolize drugs differently throughout the month due to our changing hormonal profile. I love companies like Levana.ai and their fearless leader Dr. Ilana Kwartin that are seeking to uncover these trends and enable providers to modulate care based on these findings. The future of Women’s Health must be personalized. What did you find most impactful?

Throughout the entire healthcare process—from pre-diagnosis to diagnosis, treatment, and ongoing care, women suffer from worse health outcomes and are more likely to have their concerns dismissed, misdiagnosed, or missed altogether when they do seek help. ▪ Women are more likely than men to have conditions such as chronic pain and autoimmune disease downplayed or ascribed to mental health issues. ▪ One Danish study found that women wait an average of four years longer than men to receive a diagnosis across a range of more than 700 diseases. ▪ Conditions that have been found to disproportionately affect women receive significantly lower funding relative to their burden on the population compared with conditions that disproportionately affect males. The list of health inequities goes on and holds not just women back, but our entire societies. I'm hoping this Kearney + FemTechnology Summit open letter and call to action announced today at the World Economic Forum spurs some real changes to women's healthcare around the world. For more information, see: https://bit.ly/3vHdCc7 #womenshealth #healthequity

Women are not small men! For a long time I passively assumed that, biologically, our sexual and reproductive organs are the main difference between men and women. That’s wrong. Everything about our biology is different, though science and medicine overwhelmingly treats the sexes as though we the same. This report has raised so many questions for me. How many women in my life & community are not responding well to clinical treatments because the therapies were trialed on, and designed for, male biology? How many might be enduring treatments they don’t need, or are making them worse, because at some point in the care journey their symptoms presented differently than for men? “In some cases, the same condition can have different symptoms or sets of causes; in others, a disease is more prevalent among women. Drugs and medical devices can work differently, too. For example, many drugs to treat rheumatoid arthritis are much less effective on women; ditto for asthma inhalers. Women report adverse events from approved medicines 52% more often than men–and serious ones, including fatalities, 36% more often, according to the FDA. In addition, conditions that disproportionately affect women are systematically underestimated, under-studied, and underinvested in. Only 4% of all healthcare research and development in the U.S. is specifically targeted at women’s health issues.” Read the full piece from McKinsey Health Institute Coleader & Senior Partner Lucy Perez and McKinsey & Company CMO & Senior Partner Tracy Francis in Fortune. #CloseTheWomensHealthGap #WEF24 #globalhealth #womenshealth #mckinseyatdavos

It’s a hopeful day for women's health, with the announcement of the first-ever White House Initiative on Women’s Health Research. This initiative will aim to engage government agencies, the scientific community, and the private sector to “unleash transformative investment” in women’s health research, and “spur innovation”. Emerging technologies – including at-home diagnostics, artificial intelligence, and precision medicine – are enabling new opportunities to address the gaps in women’s health. By fundamentally shifting how women’s health research and funding are approached, this initiative will make a significant difference in the lives of women, paving the way for progressive action in the United States and around the world. https://lnkd.in/gXAd8sHJ Erica Kantor #WomensHealth #Innovation 

Addressing the disparities in women's health has the potential to extend and improve the quality of life for women globally and significantly boost the global economy by an estimated $1 trillion annually by 2040. Yet, the women's health gap continues to be an industry issue. Here are 4 Underlying Causes of the Women's Health Gap 👇 1. Science 🔬: Traditional studies of human biology often focus on the male body, leading to a limited understanding of sex-based biological differences. This results in fewer and less effective treatments specifically designed for women. 2. Data 🔢: The health issues affecting women are frequently underestimated, with many datasets excluding or undervaluing critical conditions that predominantly affect women. 3. Care Delivery 👩⚕️: Women frequently encounter barriers to accessing care, experience delays in diagnosis, and often receive suboptimal treatment compared to men. 4. Investment 💰: There has historically been less investment in health conditions that primarily affect women, perpetuating a cycle of inadequate scientific understanding and insufficient data to support new investments. Together, we can close the health gap by prioritizing research, enhancing data collection, and improving care delivery, leading to better health outcomes and economic growth. https://lnkd.in/gZKa2xZ3 #palomahealth #hypothyroidism #hashimotos #thyroidcare Insights from McKinsey Global Institute

Women’s health is a historically neglected field. Fortunately, we are seeing more research as well as the development of products and therapies for women. We take a look at the top healthcare trends and future predictions for the women’s health space, including research areas, the femtech movement, and changing care pathways. Read the blog post: https://buff.ly/4eGHGqo #womenshealth #femtech

AccendoWave - A Pain #Data Company #Women spend 25% more of their lives in debilitating health than men, according to a report from the World Economic Forum and the McKinsey Health Institute. The women's health gap includes a persistent #data gap, with women being under diagnosed for certain conditions compared to men. A Top 4 Global Health Equity Solution and Top 15 Global Remote Monitoring Company, AccendoWave, benchmarks objective brain wave pain data (specialty, gender, age) and has nine #pain databases: Emergency Department, Maternal Health, Oncology, MSK, Medical Surgical, ICU, #Women, Adults, Seniors to eliminate bias, improve outcomes and reduce health care costs. If desired, AccendoWave can also create customized pain databases for partners that can be accessed on the Datavant platform.

Call #FrontiersSocioeconomicInequalitiesDigitalHealth We welcome studies (analytical, descriptive, experimental, meta-analysis, observational, review, qualitative) tackling socioeconomic inequalities. Although socioeconomic health inequalities are well studied and there is a plethora in the literature on this topic, in the era of digital health, socioeconomic inequalities can exacerbate disparities if equity is not at the forefront of digital health solutions. Keywords: Socioeconomic determinants, inequalities, digital health, policies. Topic Editors: Lua Perimal-Lewis; Sónia Vladimira Correia; Evanthia Sakellari.

Thrilled to share that OCON Therapeutics played a role in the World Economic Forum and McKinsey Health Institute's report, "Closing the Women’s Health Gap: A $1 Trillion Opportunity to Improve Lives and Economies." https://lnkd.in/edNrCEqm   🚺 Uterine Disorders in Focus: The report highlights disparities in women's health, with women spending 25% more of their lives in poor health. Gynaecological diseases contribute significantly to this health burden, impacting nearly 50% of women of working age. Conditions like endometriosis and uterine fibroids affect up to 68% of women.   🌸 Our Commitment: OCON Therapeutics is proud to champion uterine health, aligning with the Women’s Health Initiative's objectives. We're dedicated to be at the forefront of transformative solutions for a healthier future.   #WomensHealth #HealthEquity #InnovationForChange #WEF #McKinseyHealthInstitute #UterineHealth